These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547 [TBL] [Abstract][Full Text] [Related]
3. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials. Higgins JP Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585 [TBL] [Abstract][Full Text] [Related]
4. Role of Chlamydia pneumoniae in atherosclerosis. Watson C; Alp NJ Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368 [TBL] [Abstract][Full Text] [Related]
11. Chlamydia pneumoniae and atherosclerosis: the role of mast cells. Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286 [TBL] [Abstract][Full Text] [Related]
12. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease. Dugan JP; Feuge RR; Burgess DS Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941 [TBL] [Abstract][Full Text] [Related]
13. Chlamydia pneumoniae-induced pathological signaling in the vasculature. Kern JM; Maass V; Maass M FEMS Immunol Med Microbiol; 2009 Mar; 55(2):131-9. PubMed ID: 19281565 [TBL] [Abstract][Full Text] [Related]
14. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis. Yavuz MT; Yavuz O; Yazici M; Guler S; Ozhan H; Albayrak S; Coskun A Scand J Clin Lab Invest; 2006; 66(6):523-34. PubMed ID: 17000560 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of Chlamydophila pneumoniae seropositivity and risk factors in patients with atherosclerotic vascular disease in Sivas, Turkey]. Kılıç ZB; Poyraz O; Kılıç AT Mikrobiyol Bul; 2012 Jan; 46(1):156-8. PubMed ID: 22399186 [TBL] [Abstract][Full Text] [Related]
16. Is Chlamydia pneumoniae a risk factor for peripheral atherosclerosis? Ustünsoy H; Sivrikoz C; Sirmatel F; Bakir K; Burma O; Kazaz H Asian Cardiovasc Thorac Ann; 2007 Jan; 15(1):9-13. PubMed ID: 17244915 [TBL] [Abstract][Full Text] [Related]
18. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma]. Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975 [TBL] [Abstract][Full Text] [Related]
19. Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review. Vainas T; Sayed S; Bruggeman CA; Stassen FR Drugs Today (Barc); 2009 Nov; 45 Suppl B():165-72. PubMed ID: 20011710 [TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence. High KP Clin Infect Dis; 1999 Apr; 28(4):746-9. PubMed ID: 10825031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]